retatrutide study news today Use of an unapproved triple-hormone receptor agonist bought online led to extreme side effects stemming from intractable diarrhea in a man who obtained the drug online from a direct-to-customer seller. The patient 🚨Breaking: Retatrutide's first Phase 3

Notch signalling drives synovial fibroblast identity and arthritis pathology

Novo Nordisk press release, 2026 The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible beneficiaries Wegovy weight-loss access at $50/month outside Part D, not counting toward the $2,100 OOP cap

Given the pathological role of oxidative stress generation in MCP-1 induction and apoptotic cell death in tubular cells, hyperglycemia-elicited ROS generation might be a therapeutic target of tofogliflozin (157, 158)

Employers looking to develop their employees skills and distribute talent can take advantage of the opportunities revealed by these challenges.

However, neither platform conducts genetic screening for rare metabolic variants that may influence GLP-1 tolerability or efficacy

A therapeutic approach combining coenzyme Q 10 with other antioxidants might prove to be more effective to target co-existing metabolic disorders in individuals at risk for cardiovascular disease (55)